Albertsons’ 5.6x forward P/E prices in a troubled turnaround, while successful $2.0 billion cost savings and stabilized store sales could unlock asymmetric five-year upside.
Overview
Albertsons Companies is the second-largest traditional U.S. food and drug retailer, operating 2,240 stores across 35 states and the District of Columbia through 22 regional banners. Its essential-goods model generated FY2025 revenue of $83.21 billion, but recent momentum weakened: Q2 FY2026 sales were $18.895 billion, identical-store sales declined 0.8%, adjusted EBITDA fell 7.59% to $784 million, and adjusted EPS declined 18.18% to $0.36. EPS beat the $0.33 consensus, yet management withdrew FY2026 guidance and launched a comprehensive business review after leadership and board changes. ACI Edge now targets $2.0 billion in cumulative cost savings over three years. Shares near $12.25 trade at approximately 5.6x forward adjusted P/E and 3.87x EV/adjusted EBITDA, well below Kroger and sector benchmarks, reflecting market-share, leverage, and execution concerns. **The investment case is a deep-value turnaround, not a clean compounder:** the report’s probability-weighted five-year share target is $21.25, excluding dividends, versus $12.25 currently. Near-term catalysts are the Q4 FY2026 strategy framework, ACI Edge delivery, digital unit-economics improvement, and the Kroger litigation outcome.